Appendix 2—table 39. Influences on exploratory choice including WASI scores.
| Region=NY Antidiabetic Users by BP: Unmatched | Region=NY Antidiabetic Users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 104,691 | 100.0% | 95,162 | 90.9% | 9,529 | 9.1% | 18,912 | 100.0% | 9,456 | 50.0% | 9,456 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 455 | 0.4% | 454 | 0.5% | 1 | 0.0% | <0.001 | 2 | 0.0% | 1 | 0.0% | 1 | 0.0% | 1.00 |
| 21-40 | 6,164 | 5.9% | 6,152 | 6.5% | 12 | 0.1% | 25 | 0.1% | 13 | 0.1% | 12 | 0.1% | ||
| 41-50 | 10,440 | 10.0% | 10,363 | 10.9% | 77 | 0.8% | 151 | 0.8% | 75 | 0.8% | 76 | 0.8% | ||
| 51-60 | 24,366 | 23.3% | 23,532 | 24.7% | 834 | 8.8% | 1,665 | 8.8% | 831 | 8.8% | 834 | 8.8% | ||
| 61-70 | 28,819 | 27.5% | 25,939 | 27.3% | 2,880 | 30.2% | 5,741 | 30.4% | 2,870 | 30.4% | 2,871 | 30.4% | ||
| 71-80 | 24,314 | 23.2% | 20,338 | 21.4% | 3,976 | 41.7% | 7,880 | 41.7% | 3,941 | 41.7% | 3,939 | 41.7% | ||
| ≥81 | 10,133 | 9.7% | 8,384 | 8.8% | 1,749 | 18.4% | 3,448 | 18.2% | 1,725 | 18.2% | 1,723 | 18.2% | ||
| Gender | ||||||||||||||
| Female | 60,470 | 57.8% | 51,884 | 54.5% | 8,586 | 90.1% | <0.001 | 17,022 | 90.0% | 8,509 | 90.0% | 8,513 | 90.0% | 0.92 |
| Male | 44,221 | 42.2% | 43,278 | 45.5% | 943 | 9.9% | 1,890 | 10.0% | 947 | 10.0% | 943 | 10.0% | ||
| Insurance | ||||||||||||||
| Commercial | 32,100 | 30.7% | 31,172 | 32.8% | 928 | 9.7% | <0.001 | 1,849 | 9.8% | 924 | 9.8% | 925 | 9.8% | 1.00 |
| Dual | 2,193 | 2.1% | 1,693 | 1.8% | 500 | 5.2% | 978 | 5.2% | 490 | 5.2% | 488 | 5.2% | ||
| Medicaid | 27,928 | 26.7% | 25,978 | 27.3% | 1,950 | 20.5% | 3,793 | 20.1% | 1,897 | 20.1% | 1,896 | 20.1% | ||
| Medicare | 42,470 | 40.6% | 36,319 | 38.2% | 6,151 | 64.6% | 12,292 | 65.0% | 6,145 | 65.0% | 6,147 | 65.0% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 37,109 | 35.4% | 33,894 | 35.6% | 3,215 | 33.7% | <.001 | 6,363 | 33.6% | 3,182 | 33.7% | 3,181 | 33.6% | 0.99 |
| Yes | 67,582 | 64.6% | 61,268 | 64.4% | 6,314 | 66.3% | 12,549 | 66.4% | 6,274 | 66.3% | 6,275 | 66.4% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.32 | 1.79 | 1.31 | 1.79 | 1.46 | 1.87 | <0.001 | 1.44 | 1.83 | 1.44 | 1.82 | 1.45 | 1.84 | 0.75 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.